UPLOAD Filing
Clearmind Medicine Inc.
Date: Sept. 24, 2025 · CIK: 0001892500 · Accession: 0000000000-25-010438
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-290404
Letter
Re: Clearmind Medicine Inc. Registration Statement on Form F-1 Filed September 19, 2025 File No. 333-290404 Dear Adi Zuloff-Shani Ph.D.:
September 24, 2025
Adi Zuloff-Shani, Ph.D. Chief Executive Officer Clearmind Medicine Inc. 101 1220 West 6th Avenue Vancouver, British Columbia V6H1A5
This is to advise you that we have not reviewed and will not review your registration statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Chris Edwards at 202-551-6761 with any questions.
Sincerely,
Division of
Corporation Finance
Office of Life
Sciences
cc: David Huberman, Esq.
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> September 24, 2025 Adi Zuloff-Shani, Ph.D. Chief Executive Officer Clearmind Medicine Inc. 101 1220 West 6th Avenue Vancouver, British Columbia V6H1A5 Re: Clearmind Medicine Inc. Registration Statement on Form F-1 Filed September 19, 2025 File No. 333-290404 Dear Adi Zuloff-Shani Ph.D.: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Chris Edwards at 202-551-6761 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: David Huberman, Esq. </TEXT> </DOCUMENT>